Behavioral and electrophysiological effects of 5-HT in globus pallidus of 6-hydroxydopamine lesioned rats

Journal of Neuroscience Research

Volumn 88, Issue 7, 2010, Pages 1549-1556

  Zhang, Shu Jing ^a   Wang, Hua ^a,b   Xue, Yan ^a   Yung, Wing Ho ^c   Chen, Lei ^a  

^a QINGDAO UNIVERSITY   (China)

^b BINZHOU MEDICAL UNIVERSITY   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

5 hydroxytryptamine; 6 hydroxydopamine; Globus pallidus; Parkinson's disease

Indexed keywords

DOPA; LEVODOPA; OXIDOPAMINE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BODY POSTURE; BRAIN NERVE CELL; CONTROLLED STUDY; DRUG POTENTIATION; ELECTROPHYSIOLOGY; GLOBUS PALLIDUS; IN VIVO STUDY; LOCOMOTION; LOW DRUG DOSE; MALE; NERVE CELL STIMULATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; ROTATION;

ACTION POTENTIALS; ANIMALS; BEHAVIOR, ANIMAL; DOPAMINE AGENTS; DRUG COMBINATIONS; FUNCTIONAL LATERALITY; GLOBUS PALLIDUS; LEVODOPA; MALE; MICROINJECTIONS; NEURAL INHIBITION; NEURONS; NEUROTOXINS; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT1B; SEROTONIN;

EID: 77952083652     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22325     Document Type: Article

References (47)

1. 1c receptors in rat brain. J Pharmacol Exp Ther 255:843-857.
2. 4 agonist therapy reduces response fluctuations in Parkinson's disease. Parkinsonism Relat Disord 11:499-502.
3. 1A agonist in advanced Parkinson's disease. Mov Disord 20:932-936.
4. Bergman H, Feingold A, Nini A, Raz A, Slovin H, Abeles M, Vaadia E. 1998. Physiological aspects of information processing in the basal ganglia of normal and parkinsonian primates. Trends Neurosci 21:32-38. (Pubitemid 128766376)
5. Bonaventure P, Hall H, Gommeren W, Cras P, Langlois X, Jurzak M, Leysen JE. 2000. Mapping of serotonin 5-HT (4) receptor mRNA and ligand binding sites in the post-mortem human brain. Synapse 36:35-46. (Pubitemid 30134123)
6. Bonuccelli U, Del Dotto P. 2006. New pharmacologic horizons in the treatment of Parkinson disease. Neurology 67:S30-S38. (Pubitemid 44568832)
7. Boraud T, Bezard E, Guehl D, Bioulac B, Gross C. 1998. Effects of L-DOPA on neuronal activity of the globus pallidus externalis (GPe) and globus pallidus internalis (GPi) in the MPTP-treated monkey. Brain Res 787:157-160. (Pubitemid 28279814)
8. Boraud T, Bezard E, Bioulac B, Gross CE. 2001. Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey. Brain 124:546-557. (Pubitemid 32221322)
9. Charara A, Parent A. 1994. Brainstem dopaminergic, cholinergic and serotoninergic afferents to the pallidum in the squirrel monkey. Brain Res 640:155-170. (Pubitemid 24086544)
10. Chesselet MF, Delfs JM. 1996. Basal ganglia and movement disorders: an update. Trends Neurosci 19:417-422. (Pubitemid 26302073)
11. Chen L, Yung KK, Chan YS, Yung WH. 2008. 5-HT excites globus pallidus neurons by multiple receptor mechanisms. Neuroscience 151:439-451.
12. Dauer W, Przedborski S. 2003. Parkinson'sdisease:mechanismsandmodels. Neuron 39:889-909.
13. DeLong MR, Crutcher MD, Georgopoulos AP. 1985. Primate globus pallidus and subthalamic nucleus: functional organization. J Neurophysiol 53:530-543.
14. Hashimoto K, Kita H. 2008. Serotonin activates presynaptic and postsynaptic receptors in rat globus pallidus. J Neurophysiol 99:1723-1732. (Pubitemid 351550068)
15. Hornykiewicz O. 1974. The mechanisms of action of L-dopa in Parkinson's disease. Life Sci 15:1249-1259.
16. Johnston TH, Brotchie JM. 2004. Drugs in development for Parkinson's disease. Curr Opin Investig Drugs 5:720-726.
17. Kelland MD, Soltis RP, Anderson LA, Bergstrom DA, Walters JR. 1995. In vivo characterization of two cell types in the rat globus pallidus which have opposite responses to dopamine receptor stimulation: comparison of electrophysiological properties and responses to apomorphine, dizocilpine, and ketamine anesthesia. Synapse 20:338-350.
18. Kia HK, Miquel MC, Brisorgueil MJ, Daval G, Riad M, El Mestikawy S, Hamon M, Vergé D. 1996. Immunocytochemical localization of serotonin1A receptors in the rat central nervous system. J Comp Neurol 365:289-305. (Pubitemid 26040951)
19. Kish SJ. 2003. Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease. Adv Neurol 91:39-49.
20. Kita H, Chiken S, Tachibana Y, Nambu A. 2007. Serotonin modulates pallidal neuronal activity in the awake monkey. J Neurosci 27:75-83. (Pubitemid 46089961)
21. Konitsiotis S, Tsironis C. 2006. Levodopa-induced dyskinesia and rotational behavior in hemiparkinsonian rats: independent features or components of the same phenomenon? Behav Brain Res 170:337-341.
22. 1A receptor expression during memory formation. Psychopharmacology (Berl) 181:309-318.
23. Lundblad M, Andersson M, Winkler C, Kirik D, Wierup NCenci MA. 2002. Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. Eur J Neurosci 15:120-132. (Pubitemid 35478015)
24. Magill PJ, Bolam JP, Bevan MD. 2001. Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus-globus pallidus network. Neuroscience 106:313-330.
25. Mengod G, Vilaro MT, Raurich A, Lopez-Gimenez JF, Cortes R, Palacios JM. 1996. 5-HT receptors in mammalian brain: receptor autoradiography and in situ hybridization studies of new ligands and newly identified receptors. Histochem J 28:747-758. (Pubitemid 26414165)
26. Mignon L, Wolf WA. 2007. Postsynaptic 5-HT1A receptor stimulation increases motor activity in the 6-hydroxydopamine-lesioned rat: implications for treating Parkinson's disease. Psychopharmacology (Berl) 192:49-59. (Pubitemid 46673886)
27. Mink JW. 1996. The basal ganglia: focused selection and inhibition of competing motor programs. Prog Neurobiol 50:381-425.
28. Neumaier JF, Sexton TJ, Yracheta J, Diaz AM, Brownfield M. 2001. Localization of 5-HT(7) receptors in rat brain by immunocytochemistry, in situ hybridization, and agonist stimulated cFos expression. J Chem Neuroanat 21:63-73. (Pubitemid 32155392)
29. Nicholson SL, Brotchie JM. 2002. 5-hydroxytryptamine (5-HT, serotonin) and Parkinson's disease - opportunities for novel therapeutics to reduce the problems of levodopa therapy. Eur J Neurol 3:1-6.
30. Nini A, Feingold A, Slovin H, Bergman H. 1995. Neurons in the globus pallidus do not show correlated activity in the normal monkey, but phase-locked oscillations appear in the MPTP model of parkinsonism. J Neurophysiol 74:1800-1805.
31. Olsson M, Nikkhah G, Bentlage C, Bjarklund A. 1995. Forelimb akinesia in the rat Parkinson model: Differential effects of dopamine agonists and nNigral transplants as assessed by a new stepping test. J Neurosci 15:3863-3875.
32. Palkovits M, Brownstein M, Saavedra JM. 1974. Serotonin content of the brain stem nuclei in the rat. Brain Res 80:237-249.
33. Pasik P, Pasik T, Pecci-Saavedra J, Holstein GR, Yahr MD. 1984. Serotonin in pallidal neuronal circuits: an immunocytochemical study in monkeys. Adv Neurol 40:63-76.
34. Paxinos G., Watson C. 1986.The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
35. Plenz D, Kital ST. 1999. A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus. Nature 400:677-682. (Pubitemid 129516183)
36. Raz A, Vaadia E, Bergman H. 2000. Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism. J Neurosci 20:8559-8571.
37. Ruskin DN, Rawji SS, Walters JR. 1998. Effects of full D1 dopamine receptor agonists on firing rates in the globus pallidus and substantia nigra pars compacta in vivo: tests for D1 receptor selectivity and comparisons to the partial agonist SKF 38393. J Pharmacol Exp Ther 286:272-281.
38. Sari Y, Miquel MC, Brisorgueil MJ, Ruiz G, Doucet E, Hamon M, Vergé D. 1999. Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies. Neuroscience 88:899-915. (Pubitemid 28518266)
39. Schallert T, Fleming SM, Leasure JL, Tillerson JL, Bland ST. 2000. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39:777-787. (Pubitemid 30103682)
40. Simola N, Fenu S, Baraldi PG, Tabrizi MA, Morelli M. 2006. Involvement of globus pallidus in the antiparkinsonian effects of adenosine A(2A) receptor antagonists. Exp Neurol 202:255-257. (Pubitemid 44344249)
41. 2B receptor-mediated calcium release from ryanodine-sensitive intracellular stores in human pulmonary artery endothelial cells. Br J Pharmacol 117:1081-1088.
42. Vertes RP. 1991. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J Comp Neurol 313:643-668.
43. Vilaró MT, Cortés R, Gerald C, Branchek TA, Palacios JM, Mengod G. 1996. Localization of 5-HT4 receptor mRNA in rat brain by in situ hybridization histochemistry. Brain Res Mol Brain Res 43:356-360. (Pubitemid 27042427)
44. 1F receptor binding sites in the guinea pig brain: an autoradiographic study. Naunyn Schmiedebergs Arch Pharmacol 352:263-275.
45. Wichmann T, Bergman H, Starr PA, Subramanian T, Watts RL, DeLong MR. 1999. Comparison of MPTP-induced changes in spontaneous neuronal discharge in the internal pallidal segment and in the substantia nigra pars reticulata in primates. Exp Brain Res 125:397-409. (Pubitemid 29178674)
46. Wichmann T, Soares J. 2006. Neuronal firing before and after burst discharges in the monkey basal ganglia is predictably patterned in the normal state and altered in parkinsonism. J Neurophysiol 95:2120-2133.
47. Wright DE, Seroogy KB, Lundgren KH, Davis BM, Jennes L. 1995. Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain. J Comp Neurol 351:357-373.